Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis? |
Unal, Dilek
(Department of Radiation Oncology, Kayseri Education and Research Hospital)
Eroglu, Celalettin (Department of Radiation Oncology, Erciyes University Medical School) Kurtul, Neslihan (Department of Radiation Oncology, Erciyes University Medical School) Oguz, Arzu (Department of Medical Oncology, Kayseri Education and Research Hospital) Tasdemir, Arzu (Department of Pathology, Kayseri Education and Research Hospital) |
1 | Wang S, Zhang Z, Fang F, et al (2011). The neutrophil/ lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett, 2, 735-40. DOI |
2 | Yao Y, Yuan D, Liu H, Gu X, Song Y (2013). Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother, 62, 471-9. DOI ScienceOn |
3 | Zhang J, Huang SH, Li H, et al (2013). Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol, 30, 352. DOI ScienceOn |
4 | Asher V, Lee J, Innamaa A, Bali A (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503. DOI |
5 | Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7. DOI ScienceOn |
6 | Assoian RK, Sporn MB (1986). Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol, 102, 1217-23. DOI |
7 | Cedres S, Torrejon D, Martinez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9. DOI ScienceOn |
8 | Chua W, Charles KA, Baracos VE, Clarke SJ (2011). Neutrophil/ lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 104, 1288-95. DOI ScienceOn |
9 |
Divella R, Daniele A, Savino E, et al (2013). Circulating levels of transforming growth factor- |
10 | Donskov F (2013). Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol, 23, 200-7. DOI ScienceOn |
11 | Dubernard V, Arbeille BB, Lemesle MB, Legrand C (1997). Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process. Arterioscler Thromb Vasc Biol, 17, 2293-305. DOI ScienceOn |
12 | Kaplan KL, Broekman MJ, Chernoff A, Lesznik GR, Drillings M (1979). Platelet alpha-granule proteins: studies on release and subcellular localization. Blood, 53, 604-18. |
13 | Kaya MG, Akpek M, Lam YY, et al (2013). Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study. Int J Cardiol, 15, 1557-4. |
14 | Negrier S, Escudier B, Gomez F, et al (2002). Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol, 13, 1460-8. DOI ScienceOn |
15 | Kobayashi N, Usui S, Kikuchi S, et al (2012). Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer, 75, 223-7. DOI ScienceOn |
16 | Kocyigit I, Eroglu E, Unal A, et al (2013). Role of neutrophil/ lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol, 26, 358-65. DOI ScienceOn |
17 | Majeti BK, Lee JH, Simmons BH, Shojaei F (2013). VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma. BMC Cancer, 13, 213. DOI ScienceOn |
18 | Paesmans M, Sculier JP, Libert P, et al (1995). Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J Clin Oncol, 13, 1221-30. DOI |
19 | Qian X, Tuszynski GP (1996). Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med, 212, 199-207. DOI |
20 | Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T (2012). Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol, 23, 265-73. DOI ScienceOn |
21 | Schmidt H, Bastholt L, Geertsen P, et al (2005). Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer, 93, 273-8. DOI ScienceOn |
22 | Stone RL, Nick AM, McNeish IA, et al (2012). Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med, 366, 610-8. DOI ScienceOn |
23 | Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8. DOI ScienceOn |
24 | Tomita M, Shimizu T, Ayabe T, Nakamura K, Onitsuka T (2012). Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer Res, 32, 3535-8. |
25 | Wang D, Yang JX, Cao DY, et al (2013). Preoperative neutrophillymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther, 6, 211-6. |
![]() |